Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,459,302 | 968,086 | 816,007 | 707,913 | 280,909 |
| Marketable Securities | 330,760 | 203,892 | 120,844 | 1,603,120 | 973,129 |
| Receivables | 1,023,397 | 795,127 | 609,320 | 396,125 | 371,245 |
| Inventories | 927,868 | 599,966 | 564,145 | 216,903 | 135,991 |
| Income taxes - deferred | 140,882 | 152,533 | 245,916 | 84,839 | 53,047 |
| Other current assets | 126,066 | 35,242 | 22,863 | 34,925 | 13,692 |
| TOTAL | $4,278,408 | $3,028,292 | $2,429,206 | $3,092,208 | $1,849,694 |
| Non-Current Assets | |||||
| PPE Net | 528,799 | 447,696 | 361,299 | 242,568 | 223,106 |
| Investments And Advances | 1,449,577 | 1,550,444 | 452,715 | 0 | 0 |
| Intangibles | 123,008 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 557,039 | 808,284 | 842,761 | 431,540 | 83,163 |
| TOTAL | $2,658,423 | $2,806,424 | $1,656,775 | $674,108 | $306,269 |
| Total Assets | $6,936,831 | $5,834,716 | $4,085,981 | $3,766,316 | $2,155,963 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,631 | 286 | 18,747 | 60,206 | 181 |
| Accounts payable and accrued liabilities | 601,200 | 290,333 | 367,029 | 70,908 | 47,552 |
| Accrued Expenses | 280,779 | 251,688 | 75,659 | 70,441 | 53,016 |
| TOTAL | $1,220,992 | $736,275 | $764,276 | $465,163 | $253,453 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,462 | 11,604 | 91,847 | 240,650 | 234 |
| Deferred Revenues | 42,963 | 30,747 | 17,777 | 18,353 | 19,880 |
| Other Non-Current Liabilities | 1,163,177 | 1,574,639 | 1,353,091 | 0 | 0 |
| TOTAL | $1,250,256 | $1,638,451 | $1,505,987 | $273,375 | $31,638 |
| Total Liabilities | $2,471,248 | $2,374,726 | $2,270,263 | $738,538 | $285,091 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,821,909 | 1,857,740 | 1,858,656 | 1,849,139 | 1,799,527 |
| Common Shares | 910 | 932 | 922 | 460 | 449 |
| Retained earnings | 300,314 | 249,080 | -891,363 | 809,642 | -4,272 |
| Other shareholders' equity | 234,250 | -4,363 | 2,221 | 11,448 | -19,231 |
| TOTAL | $4,465,583 | $3,459,990 | $1,815,718 | $3,027,778 | $1,870,872 |
| Total Liabilities And Equity | $6,936,831 | $5,834,716 | $4,085,981 | $3,766,316 | $2,155,963 |